Clinical Trial

Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors

Study acronym: PREMOD
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn how tumor tissue and blood samples from patients with sarcomas or metastases can be used to create laboratory models that help researchers study cancer behavior and test new treatments. Participants diagnosed with sarcoma or with bone or lung metastases from solid tumors will donate leftover tumor tissue and blood collected during their regular medical care. These samples will be used in the lab to build 3D models of the tumor, test drugs, and identify genetic and molecular markers. No treatments or procedures will be given as part of the study.
Trial Details
NCT Number NCT07112989
Lead Sponsor Istituto Ortopedico Rizzoli
Conditions Bone and Soft Tissue Tumors, Bone Metastases From Solid Tumors, Lung Metastases
Enrollment 125 participants
Start Date 2024-09-23
Primary Completion 2031-09-23 (estimated)
Study Completion 2031-09-23 (estimated)
Updated on ClinicalTrials.gov 2025-08-08